Clinical Trial Update: Apixaban Dose Reduction in Patients With Elevated Drug Levels [Phase 2]

View source ↗

Summary

A Phase 2 trial update on reducing the apixaban dose for patients with elevated drug levels in atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Apixaban (apixaban)

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Atrial Fibrillation | Phase 2 | Status: UNKNOWN